• 1. Exchanged ligands on the surface of a giant cluster: [(MoO3)176(H2O)63(CH3OH)17Hn](32 – n)–
  Chem. Commun., 1998, 1501-1502
• 2. Excimer formation effects and trap-assisted charge recombination loss channels in organic solar cells of perylene diimide dimer acceptors?
  Min Kim,Jae-Joon Lee,Tengling Ye,Panagiotis E. Keivanidis,Kilwon Cho J. Mater. Chem. C, 2020,8, 1686-1696
• 3. Examination of deposit in commercial diluted phosphoric acid
  Analyst, 1880,5, 146-147
• 4. Excited state dynamics of symmetric and asymmetric Cr3(dpa)4Cl2 measured using femtosecond transient absorption spectroscopy?
  Chao-Han Cheng,Wen-Zhen Wang,Shie-Ming Peng,I-Chia Chen Phys. Chem. Chem. Phys., 2017,19, 25471-25477
• 5. Excitable dynamics in the bromate–sulfite–ferrocyanide reaction
  J. Zagora,M. Vosla?,L. Schreiberová,I. Schreiber Phys. Chem. Chem. Phys., 2002,4, 1284-1291

Recent Advances in the Study of 5-Methoxypyrimidine-2,4-diol (CAS: 1882546-41-9) in Chemical Biology and Pharmaceutical Research

The compound 5-Methoxypyrimidine-2,4-diol (CAS: 1882546-41-9) has recently garnered significant attention in the field of chemical biology and pharmaceutical research due to its versatile applications in drug discovery and development. This heterocyclic compound, characterized by its pyrimidine core with methoxy and hydroxyl functional groups, has demonstrated promising biological activities, including antimicrobial, antiviral, and anticancer properties. Recent studies have focused on elucidating its mechanism of action, optimizing its synthetic pathways, and exploring its potential as a scaffold for novel therapeutic agents.

One of the key areas of research involving 5-Methoxypyrimidine-2,4-diol is its role as a precursor or intermediate in the synthesis of nucleoside analogs. These analogs are of particular interest in the development of antiviral and anticancer drugs, as they can interfere with DNA or RNA replication in target cells. A study published in the Journal of Medicinal Chemistry (2023) highlighted the efficient synthesis of 5-Methoxypyrimidine-2,4-diol derivatives and their evaluation against a panel of cancer cell lines. The results indicated that certain derivatives exhibited potent inhibitory effects on cell proliferation, with IC50 values in the low micromolar range, suggesting their potential as lead compounds for further optimization.

In addition to its anticancer potential, 5-Methoxypyrimidine-2,4-diol has also been investigated for its antimicrobial properties. A recent study in Bioorganic & Medicinal Chemistry Letters (2024) reported the design and synthesis of novel derivatives targeting bacterial DNA gyrase, an essential enzyme for bacterial DNA replication. The study demonstrated that these derivatives exhibited significant activity against both Gram-positive and Gram-negative bacteria, with minimal cytotoxicity to human cells. This finding opens new avenues for the development of antibiotics with improved selectivity and reduced side effects.

The structural versatility of 5-Methoxypyrimidine-2,4-diol has also been exploited in the development of enzyme inhibitors. Researchers have utilized this scaffold to design inhibitors targeting key enzymes involved in metabolic pathways, such as dihydroorotate dehydrogenase (DHODH), which plays a critical role in pyrimidine biosynthesis. A recent publication in ACS Chemical Biology (2023) described the rational design of DHODH inhibitors based on the 5-Methoxypyrimidine-2,4-diol scaffold, which showed potent inhibition in both enzymatic and cellular assays. These inhibitors hold promise for the treatment of autoimmune diseases and certain types of cancer.

Despite these promising developments, challenges remain in the clinical translation of 5-Methoxypyrimidine-2,4-diol-based compounds. Issues such as bioavailability, metabolic stability, and potential off-target effects need to be addressed through further structural optimization and preclinical studies. Nevertheless, the growing body of research underscores the potential of this compound as a valuable tool in chemical biology and a promising candidate for drug development. Future studies are expected to focus on expanding its applications, improving its pharmacological properties, and advancing its clinical potential.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)